Endothelin: A New Challenge

Journal of Medicinal Chemistry

Volumn 35, Issue 9, 1992, Pages 1493-1508

  Doherty, Annette M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; RECEPTOR BLOCKING AGENT;

BIOSYNTHESIS; BRONCHOSPASM; CARDIOVASCULAR EFFECT; CHEMOTAXIS; DIABETES MELLITUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; GASTROINTESTINAL DISEASE; KIDNEY FUNCTION; MITOGENESIS; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; VASOCONSTRICTION; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMAL; ASPARTIC ENDOPEPTIDASES; CARDIOVASCULAR AGENTS; ENDOTHELINS; HUMAN; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; RECEPTORS, ENDOTHELIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0026764585     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00087a001     Document Type: Article

References (177)

1. Ganten, D. Peptidergic control of cardiovascular function: the angiotensin paradigm. Eur. Heart J. 1990,11, 72-78.
2. Said, S. I. Vasoactive peptides. Hypertension 1983,5,17-26.
3. Moine, M. C.; Ralevic, V.; Burnstock, G. Peptides and vasomotor mechanisms. Pharmacol. Ther. 1990, 46, 429-468.
4. Wharton, J.; Gulbenkian, S. Peptides in the mammalian cardiovascular system. Experientia Suppl. 1989, 56, 292-316.
5. Doherty, A. M. Endogenous vasoactive peptides. Anna. Rep. Med. Chem. 1991,26, 83-92.
6. Vasodilation: Vascular smooth muscle, peptides, autonomic nerves, and endothelium; Vanhoutte, P. M., Ed.; Raven Press: New York, 1988.
7. Progress in Atrial Peptide Research. Symposium Series; Brenner, B. M., Laragh, J. H., Eds.; Raven Press: New York, 1989; Vol. 3.
8. Kramer, H. J. Atrial Natriuretic hormones. Am. J. Hypertens. 1990,13, 747-753.
9. Luscher, T. F. Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? Am. J. Hypertens. 1990, 3, 317-330.
10. Vanhoutte, P. M. Endothelium and control of vascular function. State of the Art lecture. Hypertension 1989,13, 658-667.
11. Whittle, B. J.; Lopez, B. J.; Rees, D. D. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 1989, 98, 646-652.
12. Moncada, S.; Palmer, R. M. J.; Higgs, E. A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988, 12, 365-372.
13. Yanagisawa, M.; Masaki, T. Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem. Pharmacol. 1989, 38, 1877-1883.
14. Masaki, T.; Yanagisawa, M.; Inoue, A.; Takuwa, Y.; Goto, K.; Kimura, S. Biological activity of endothelin. J. Cell. Biochem. 1990, 14E, 199.
15. Hickey, K. A.; Rubanyi, G.; Paul, R. J.; Highsmith, R. F. Characterization of a coronary vasoconstrictor produced by endothelial cells in culture. Am. J. Physiol. 1985, 248, C550-C556.
16. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K.; Masaki, T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 1988, 332, 411-415.
17. Itoh, Y.; Yanagisawa, M.; Ohkubo, S.; Kimura, C.; Kosaka, T.; Inoue, A.; Ishida, N.; Mitsui, Y.; Onda, H.; Fujino, M.; et al. Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: Identity of human and porcine endothelin. FEBS Lett. 1988, 231, 440-444.
18. Inoue, A.; Yanagisawa, M.; Kimura, S.; Kasuya, Y.; Miyauchi, T.; Goto, K.; Masaki, T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 2863-2867.
19. Shinmi, O.; Kimura, S.; Sawamura, T.; Sugita, Y.; Yoshizawa, T.; Uchiyama, Y.; Yanagisawa, M.; Goto, K.; Masaki, T.; Kanazawa, I. Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem. Biophys. Res. Commun. 1989, 164, 587-593.
20. Yanagisawa, M.; Inoue, A.; Ishikawa, T.; Kasuya, Y.; Kimura, S.; Kumagaye, S.; Nakajima, K.; Watanabe, T. X.; Sakakibara, S.; Goto, K.; et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 6964-6967.
21. Saida, K.; Mitsui, Y.; Ishida, N. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity. J. Biol. Chem. 1989, 264, 14613-14616.
22. Kloog, Y.; Ambar, I.; Sokolovsky, M.; Kochva, E.; Wollberg, Z.; Bdolah, A. Sarafotoxin, a novel vasoconstrictor peptide: Phosphoinositide hydrolysis in rat heart and brain. Science 1988, 242, 268-270.
23. Bdolah, A.; Wollberg, Z.; Fleminger, G.; Kochva, E. SRTX-d, a new native peptide of the endothelin/sarafotoxin family. FEBS Lett. 1989, 256, 1-3.
24. Watanabe, T.; Itoh, Y.; Ogi, K.; Kimura, C.; Suzuki, N.; Onda, H. Synthesis of human endothelin-1 precursors in Escherichia coli. FEBS Lett. 1989, 251, 257-260.
25. Yanagisawa, M.; Masaki, T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 1989,10, 374-378.
26. Kimura, S.; Kasuya, Y.; Sawamura, T.; Shinimi, O.; Sugita, Y.; Yanagisawa, M.; Goto, K.; Masaki, T. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J. Cardiovasc. Pharmacol. 1989,13, S5-S7.
27. Okada, K.; Takada, J.; Arai, Y.; Matsuyama, K.; Yano, M. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelinconverting enzyme. Biochem. Biophys. Res. Commun. 1991, 180 (2), 1019-1023.
28. Nunez, D. J.; Brown, M. J.; Davenport, A. P.; Neylon, C. B.; Schofield, J. P.; Wyse, R. K. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J. Clin. Invest. 1990, 85, 1537-1541.
29. Kitamura, K.; Yukawa, T.; Morita, S.; Ichiki, Y.; Eto, T.; Tanaka, K. Distribution and molecular form of immunoreactive big endothelin-1 in porcine tissue. Biochem. Biophys. Res. Commun. 1990, 170, 497-503.
30. Cornet, S.; Braillon, A.; Guilmard, C.; Chabrier, P. E.; Pirotzky, E.; Braquet, P. Involvement of endothelin in renal processes. Hypertension 1990,15, 724-728.
31. Sakamoto, H.; Sasaki, S.; Hirata, Y.; Imai, T.; Ando, K.; Ida, T.; Sakurai, T.; Yanagisawa, M.; Masaki, T.; Marumo, F. Production of endothelin-1 by rat cultured mesangial cells. Biochem. Biophys. Res. Commun. 1990,169, 462-468.
32. Kosaka, T.; Suzuki, N.; Matsumoto, H.; Itoh, Y.; Yasuhara, T.; Onda, H.; Fujino, M. Synthesis of the vasoconstrictor peptide endothelin in kidney cells. FEBS Lett. 1989, 249, 42-46.
33. Marumo, F.; Tomita, K. Secretion of endothelin and related peptides from renal epithelial cell lines. Jpn. J. Physiol. 1990, 40, S77.
34. Kusuhara, M.; Yamaguchi, K.; Nagasaki, K.; Hayashi, C.; Suzaki, A.; Hori, S.; Handa, S.; Nakamura, Y.; Abe, K. Production of endothelin in human cancer cell lines. Cancer Res. 1990, 50, 3257-3261.
35. Ehrenreich, H.; Anderson, R. W.; Fox, C. H.; Rieckmann, P.; Hoffman, G. S.; Travis, W. D.; Coligan, J. E.; Kehrl, J. H.; Fauci, A. S. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 1990,172, 1741-1748.
36. Lee, M. E.; de la Monte, S. M.; Ng, S.-C.; Bloch, K. D.; Quertermous, T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J. Clin. Invest. 1990, 86, 141-147.
37. Onda, H.; Ohkubo, S.; Ogi, K.; Kosaka, T.; Kimura, C.; Matsumoto, H.; Suzuki, N.; Fujino, M. One of the endothelin gene family, endothelin 3 gene, is expressed in the placenta. FEBS Lett. 1990, 261, 327-330.
38. Ohkubo, S.; Ogi, K.; Hosoya, M.; Matsumoto, H.; Suzuki, N.; Kimura, C.; Ondo, H.; Fujino, M. Specific expression of human endothelin-2 (ET-2) gene in a renal adrenocarcinoma cell line. Molecular cloning of cDNA encoding the precursor of ET-2 and its characterization. FEBS Lett. 1990, 274, 136-140.
39. Milner, P.; Bodin, P.; Loesch, A.; Burnstock, G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem. Biophys. Res. Commun. 1990, 170, 649-656.
40. Hieda, H. S.; Gomez-Sanchez, C. E. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci. 1990, 47, 247-251.
41. Cocks, T. M.; Malta, E.; Woods, R. L.; King, S. J.; Angus, J. A. Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur. J. Pharmacol. 1991,196, 177-182.
42. Yamauchi, T.; Ohnaka, K.; Takayanagi, R.; Umeda, F.; Nawata, H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 1990, 267,16-18.
43. Yamada, K.; Goto, A.; Hui, C.; Sugimoto, T. Endogenous digitalis-like factor as a stimulator of endothelin secretion from endothelial cells. Biochem. Biophys. Res. Commun. 1990,172,178-183.
44. Boulanger, C.; Luscher, T. F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 1990, 85, 587-590.
45. Lerman, A.; Hildebrand, F. L.; Margulies, K. B.; O'Murchu, B. ; Perrella, M. A.; Heublein, D. M.; Schwab, T. R. Burnett, J. C. Endothelin: A new cardiovascular regulatory peptide. Mayo Clin. Proc. 1990, 65,1441-1455.
46. Anggard, E. E.; Botting, R. M.; Vane, J. R. Endothelins. Blood Vessels 1990, 27, 269-281.
47. Lovenburg, W.; Miller, R. C. Endothelin: A review of its effects and possible mechanisms of action. Neurochem. Res. 1990,14, 407-417.
48. Miyauchi, T.; Tomobe, Y.; Shiba, R.; Ishikawa, T.; Yanagisawa, M.; Kimura, S.; Sugishita, Y.; Ito, I.; Goto, K.; Masaki, T. Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990, 81, 1874-1880.
49. Masaki, T.; Yanagisawa, M. Cardiovascular effects of the endothelins. Cardiovasc. Drug Rev. 1990, 8, 373-385.
50. Mortensen, L. H.; Pawloski, C. M.; Kanagy, N. L.; Fink, G. D. Chronic hypertension produced by infusion of endothelin in rats. Hypertension 1990,15, 729-733.
51. Le Monnier de Gouville, A. C.; Mondot, S.; Lippton, H.; Hyman, A.; Cavero, I. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. J. Pharmacol. Exp. Ther. 1990, 252, 300-311.
52. Yang, Z. H.; Richard, V.; von Segesser, L.; Bauer, E.; Stulz, P.; Turina, M.; Luscher, T. F. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990, 82,188-195.
53. Minkes, R. K.; Higuera, T. R.; Rogers, G. F.; Sheldon, E. A.; Langston, M. A.; Kadowitz, P. J. Cardiovascular responses to vasoactive intestinal contractor, a novel endothelin-like peptide. Am. J. Physiol. 1990, 259, H1152-H1160.
54. Minkes, R. K.; Kadowitz, P. J. Comparative responses to endothelin 2 and sarafotoxin 6b in systemic vascular bed of cats. Am. J. Physiol. 1990, 258, H1550-H1558.
55. Han, S.-P.; Knuepfer, M. M.; Trapani, A. J.; Fok, K. F.; Westfall, T. C. Cardiac and vascular actions of sarafotoxin S6b and endothelin-1. Life Sci. 1990, 46, 767-775.
56. Nakamoto, H.; Suzuki, H.; Murakami, M.; Kageyama, Y.; Naitoh, M.; Sakamaki, Y.; Ohishi, A.; Saruta, T. Different effects of low and high doses of endothelin on hemodynamics and hormones in the normotensive conscious dog. J. Hypertension 1991, 9, 337-344.
57. Wright, C. E.; Fozard, J. R. Regional vasodilation is a prominant feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur. J. Pharmacol. 1988,155, 201-203.
58. Hoffman, A.; Grossman, E.; Ohman, K. P.; Marks, E.; Reiser, H. R. The initial vasodilation and the later vasoconstriction of endothelin-1 are selective to specific vascular beds. Am. J. Hypertension 1990, 3, 789-791.
59. Fukuda, N.; Soma, M.; Izumi, Y.; Minato, M.; Watanabe, M.; Hatano, M. Low doses of endothelin-3 elicit endothelium dependent vasodilation which is accompanied by elevation of cyclic GMP. Jpn Circ. J. 1991, 55, 618-623.
60. Takayanagi, R.; Kitazumi, K.; Takasaki, C.; Ohnaka, K.; Aimotyo, S.; Tasaka, K.; Ohashi, M.; Nawata, H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 1991, 282, 103-106.
61. Vierhapper, H.; Wagner, O.; Nowotny, P.; Waldhausl, W. Effect of endothelin-1 in man. Circulation 1990, 81, 1415-1418.
62. Saito, Y.; Nakao, K.; Mukoyama, M.; Shirakami, G.; Itoh, H.; Yamada, T.; Arai, H.; Hosoda, K.; Suga, S.; Jougasaki, M.; Ogawa, Y.; Nakajima, S.; Ueda, M.; Imura, H. Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 1990,15, 734-738.
63. Margulies, R. B.; Hildebrand, F. L.; Lerman, A.; Perrella, M. A.; Burnett, J. J. C. Increased endothelin in experimental heart failure. Circulation 1990, 82, 2226-2230.
64. Watanabe, T.; Suzuki, N.; Shimamoto, N.; Fujino, M.; Imada, A. Endothelin in myocardial infarction. Nature (London) 1990, 344, 114.
65. Cavero, P. G.; Miller, W. L.; Heublein, D. M.; Margulies, R. B. ; Burnett, J. C. Endothelin in experimental congestive heart failure in the anesthetized dog. Am. J. Physiol. 1990, 259, F312-F317.
66. Rodeheffer, R. J.; Lerman, A.; Heublein, D. M.; Burnett, J. C. Circulating plasma endothelin correlates with the severity of congestive heart failure in humans. Am. J. Hypertension 1991, 4, 9A-10A.
67. Fortes, Z. B.; de Nucci, G.; Garcia, L. J. Effect of endothelin-1 on arterioles and venules in vivo. J. Cardiovasc. Pharmacol. 1989,13 (Suppl. 5), S200-S201.
68. Saito, A.; Shiba, R.; Kimura, S.; Yanagisawa, M.; Goto, K.; Masaki, T. Vasoconstrictor response of large cerebral arteries of cats to endothelin, an endothelium-derived vasoactive peptide. Eur. J. Pharmacol. 1989,162, 353-358.
69. Hirata, Y.; Takagi, Y.; Fukuda, Y.; Marumo, F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989, 78, 225-228.
70. de Nucci, G.; Thomas, G. R.; D'Orleans-Juste, P.; Antunes, E.; Walder, C.; Warner, T. D.; Vane, J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 9797-9800.
71. Fukuda, K.; Hori, S.; Kusuhara, M.; Satoh, T.; Kyotani, S.; Handa, S.; Nakamura, Y.; Oono, H.; Yamaguchi, K. Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart. Eur. J. Pharmacol. 1989, 165, 301-304.
72. Han, S. P.; Trapani, A. J.; Fok, K. F.; Westfall, T. C.; Knuepfer, M. M. Effects of endothelin on regional hemodynamics in conscious rats. Eur. J. Pharmacol. 1989, 159, 303-305.
73. Moravec, C. S.; Reynolds, E. E.; Stewart, R. W.; Bond, M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun. 1989,159, 14-18.
74. Ishikawa, T.; Yanagisawa, M.; Kimura, S.; Goto, K.; Masaki, T. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch. 1988, 413, 108-110.
75. Winquist, R. J.; Scott, A. L.; Vlasuk, G. P. Enhanced release of atrial natriuretic factor of endothelin in atria from hypertensive rats. Hypertension 1989,14, 111-114.
76. Reid, J. J.; Wong, D. H.; Rand, M. J. The effect of endothelin on noradrenergic transmission in rat and guinea-pig atria. Eur. J. Pharmacol. 1989,168, 93-96.
77. Rakugi, H.; Nakamaru, M.; Saito, H.; Higaki, J.; Ogihara, T. Endothelin inhibits renin release from isolated rat glomeruli. Biochem. Biophys. Res. Commun. 1988, 155, 1244-1247.
78. Cozza, E. N.; Gomez, S. C.; Foecking, M. F.; Chiou, S. Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J. Clin. Invest. 1989, 84, 1032-1035.
79. Boarder, M. R.; Marriott, D. B. Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J. Cardiovasc. Pharmacol. 1989,13 (Suppl. 5), S223-224.
80. Topouzis, S.; Pelton, J. T.; Miller, R. C. Effects of calcium entry blockers on contractions evoked by endothelin-1. [Ala3,u]endothelin-l and [Ala1,16] endothelin-1 in rat isolated aorta. Br. J. Pharmacol. 1989, 98, 669-677.
81. Danthuluri, N. R.; Brock, T. A. Endothelin receptor-coupling mechanisms in vascular smooth muscle: a role for protein kinase C. J. Pharmacol. Exp. Ther. 1990, 254, 393-399.
82. Criscione, L.; Thomann, H.; Rodriguez, C.; Egleme, C.; Chiesi, M. Blockade of endothelin-induced contractions by dichlorobenzamil: mechanism of action. Biochem. Biophys. Res. Commun. 1989,163, 247-254.
83. Ohlstein, E. H.; Horohonich, S.; Hay, D. W. Cellular mechanisms of endothelin in rabbit aorta. J. Pharmacol. Exp. Ther. 1989, 250, 548-555.
84. Simonson, M. S.; Dunn, M. J. Cellular signaling by peptides of the endothelin gene family. FASEB J. 1990,4, 2989-3000.
85. Reynolds, E.; Mok, L. Endothelin-stimulated arachidonic acid release in vascular smooth muscle cells. FASEB J. 1991, 5, A1066.
86. Miura, K.; Yukimura, T.; Yamashita, Y.; Shichino, K.; Shimmen, T.; Saito, M.; Okumura, M.; Imanishi, M.; Yamanaka, S.; Yamamoto, K. Effects of endothelin on renal hemodynamics and renal function in anesthetized dogs. Am. J. Hyper tens. 1990, 3, 632-634.
87. Hoffman, A.; Grossman, E.; Reiser, H. R. Opposite effects of endothelin-1 and Big-endothelin-(l-39) on renal function in rats. Eur. J. Pharmacol. 1990,182, 603-606.
88. Yokokawa, K.; Kohno, M.; Murakawa, K.; Yasunari, K.; Inoue, T.; Takeda, T. Effects of endothelin on blood pressure and renal hemodynamics in DOCA-salt hypertensive rats under conscious and unrestrained condition. Clin. Exp. Hypertens. 1990,12, 1049-1062.
89. Lopez-Farre, A.; Gomez-Garre, D.; Bernabeu, F.; Montanes, I.; Millas, I.; Lopez-Novoa, J. M. Renal effects and mesangial cell contraction induced by endothelin are medkted by PAF. Kidney Int. 1991, 39, 624-630.
90. Nambi, P.; Pullen, M.; Contino, L. C.; Brooks, D. P. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur. J. Pharmacol. 1990,187, 113-116.
91. Kon, V.; Yoshioka, T.; Fogo, A.; Ichikawa, I. Glomerular actions of endothelin in vivo. J. Clin. Invest. 1989, 83, 1762-1767.
92. Bobik, A.; Grooms, A.; Millar, J. A.; Mitchell, A.; Grinpukel, S. Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 1990, 258, C408-415.
93. Weissburg, P. L.; Witchell, C.; Davenport, A. P.; Hesketh, T. R.; Metcalfe, J. C. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 1990, 85, 257-262.
94. MacCumber, M. W.; Ross, C. A.; Snyder, S. H. Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 2359-2363.
95. Neuser, D.; Knorr, A.; Stasch, J. P.; Kazda, S. Mitogenic activity of endothelin-1 and -3 on vascular smooth muscle cells is inhibited by atrial natriuretic peptides. Artery 1990, 17, 311-324.
96. Fabregat, I.; Rozengurt, E. [D-Arg1,D-Phe6,D-Trp7'9,Leun]-substance P, a neuropeptide antagonist, blocks binding, Ca2+-mobilizing, and mitogenic effects of endothelin and vasoactive intestinal contractor in mouse 3T3 cells. J. Cell Physiol. 1990,145, 88-94.
97. Edlund, A.; Wennmalm, A. Endothelin does not affect aggregation of human platelets. Clin. Physiol. 1990, 10, 585-590.
98. Thiemermann, C.; Lidbury, P. S.; Thomas, G. R.; Vane, J. R. Endothelin-1 inhibits ex vivo platelet aggregation in the rabbit. Eur. J. Pharmacol. 1988, 158, 182-186.
99. Ohlstein, E. H.; Storer, B. L.; Butcher, J. A.; Debouck, C.; Feuerstein, G. Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circulation Res. 1991, 69, 832-841.
100. Wright, C. D.; Cody, W. L.; Dunbar, J. B.; Doherty, A. M.; Rapundalo, S. T. Characterization of the chemotactic activity of endothelins and peptide fragments for human neutrophils. FASEB J. 1991, 5 (4), A637.
101. Cody, W. L.; Doherty, A. M.; He, X.; Rapundalo, S. T.; Hingorani, G. P.; Panek, R. B.; Major, T. C. Monocyclic Endothelins: Examination of the individual disulfide rings. J. Cardiovasc. Pharmacol. 1991,17 (Suppl. 7), S62-S64.
102. Lagente, V.; Touvay, C.; Mencia-Huerta, J.; Chabrier, P. E.; Braquet, P. Bronchopulmonary effects of endothelin. Clin. Exp. Allergy 1990, 20, 343-348.
103. Battistini, B.; Sirios, P.; Braquet, P.; Filep, J. G. Endothelin-induced constriction of guinea-pig airways: role of platelet-activating factor. Eur. J. Pharmacol. 1990, 186, 307-310.
104. Filep, J. G.; Battistini, B.; Sirois, P. Endothelin induces thromboxane release and contraction of isolated guinea-pig airways. Life Sci. 1990, 47,1845-1850.
105. Lippton, H. L.; Cohen, G. A.; McMurtry, I. F.; Hyman, A. L. Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J. Appl. Physiol. 1991, 70 (2), 947-952.
106. Giaid, A.; Polak, J. M.; Gaitonde, V.; Hamid, Q. A.; Moscoso, G.; Legon, S.; Uwanogho, D.; Roncalli, M.; Shinmi, O.; Sawamura, T. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am. J. Respir. Cell. Mol. Biol. 1991, 4, 50-58.
107. Nomura, A.; Uchida, Y.; Kameyama, M.; Saotome, M.; Oki, K.; Hasegawa, S. Endothelin and bronchial asthma. Lancet 1989, 2 (8665), 747-748.
108. Takahashi, K.; Jones, F. M.; Kanse, S. M.; Lam, H. C.; Spokes, R. A.; Ghatei, M. A.; Bloom, S. R. Endothelin in the gastrointestinal tract. Presence of endothelin like immunoreactivity, endothelin-1 messenger RNA, endothelin receptors, and pharmacological effect. Gastroenterology 1990,99, 1660-1667.
109. Wallace, J. L.; Cirino, G.; De Nucci, G.; McKnight, W.; MacNaughton, W. K. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am. J. Physiol. 1989, 256, G661-G666.
110. Takahashi, K.; Ghatei, M. A.; Jones, P. M.; Murphy, J. K.; Lam, H. C.; O'Halloran, D. J.; Bloom, S. R. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J. Clin. Endocrinol. Metab. 1991, 72, 693-699.
111. Gaiad, A.; Gibson, S. J.; Herrero, M. T.; Gentleman, S.; Legon, S.; Yanagisawa, M.; Masaki, M.; Ibrahim, N. B. N.; Roberts, G. W.; Rossi, M. L.; Polak, J. M. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 1991, 95, 303-314.
112. Ehrenreich, H.; Kehrl, J. H.; Anderson, R. W.; Reickmann, P.; Vitkovic, L.; Coligan, J. E.; Fauci, A. S. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res. 1991, 538, 54-58.
113. Calvo, J. J.; Gonzalez, R.; De Carvalho, L.; Takahashi, K.; Kanse, S. M.; Hart, G. R.; Ghatei, M. A.; Bloom, S. R. Release of substance P from rat hypothalamus and pituitary by endothelin. Endocrinology 1990,126, 2288-2295.
114. Nishimura, M.; Takahashi, H.; Matsusawa, M.; Ikegaki, I.; Nakanishi, T.; Hirabayashi, M.; Yoshimura, M. Intracerebroventricular injections of endothelin increase arterial pressure in conscious rats. Jpn Circ. J. 1990, 54, 662-670.
115. Stojilkovic, S. S.; Merelli, F.; Iida, T.; Krsmanovic, L. Z.; Catt, K. J. Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 1990, 248, 1663-1666.
116. Kanyicska, B.; Burris, T. P.; Freeman, M. E. Endothelin-3 inhibits prolactin and stimulates LH, FSH and TSH secretion from pituitary cell culture. Biochem. Biophys. Res. Commun. 1991,174, 338-343.
117. Suzuki, H.; Sato, S.; Suzuki, Y.; Takekoshi, K.; Ishihara, N.; Shimoda, S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol. Scand. 1990, 81, 553-554.
118. Gandhi, C. R.; Stephenson, K.; Olson, M. S. Endothelin, a potent peptide agonist in the liver. J. Biol. Chem. 1990,265, 17432-17435.
119. Oliver, F. J.; de la Rubia, G.; Feener, E. P.; Lee, M.-E.; Loeken, M.; Shiba, T.; Quertermous, T.; King, G. L. Stimulation of endothelin-1 expression by insulin in endothelial cells. J. Biol. Chem. 1991, 266, 23251-23256.
120. Benigni, A.; Gaspari, F.; Orisio, S.; Bellizzi, L.; Amuso, G.; Frusca, T.; Remuzzi, G. Human placenta expresses endothelin gene and corresponding protein is excreted in urine in increasing amounts during normal pregnancy. Am. J. Obstet. Gynecol. 1991, 164, 844-848.
121. Davenport, A. P.; Cameron, I. T.; Smith, S. K.; Brown, M. J. Binding sites for iodinated endothelin-1, endothelin-2 and endothelin-3 demonstrated on human uterine glandular epithelial cells by quantitative high resolution autoradiography. J. Endocrinol. 1991, 129, 149-154.
122. Lerman, A.; Hildebrand, F. L.; Aarhus, L. L.; Burnett, J. C. Endothelin has biological actions at pathophysiological concentrations. Circulation 1991, 83, 1808-1814.
123. Ikegawa, R.; Matsumura, Y.; Takaoka, M.; Morimoto, S. Evidence for pepstatin-sensitive conversion of porcine big endothelin-1 to endothelin-1 by the endothelial cell extract. Biochem. Biophys. Res. Commun. 1990,167, 860-866.
124. Sawamura, TV, Kimura, S.; Shinmi, O.; Sugita, Y.; Kobayashi, M.; Mitsui, Y.; Yanagisawa, M.; Goto, K.; Masaki, T. Characterization of endothelin converting enzyme activities in soluble fraction of bovine cultured endothelial cells. Biochem. Biophys. Res. Commun. 1990, 169, 1138-1144.
125. Sawamura, T.; Shinmi, O.; Kishi, N.; Sugita, Y.; Yanagisawa, M.; Goto, K.; Masaki, T.; Kimura, S. Analysis of big endothelin-1 digestion by cathepsin D. Biochem. Biophys. Res. Commun. 1990,172, 883-889.
126. Lees, W. E.; Kalinka, S.; Meech, J.; Capper, S. J.; Cook, N. D.; Kay, J. Generation of human endothelin by cathepsin E. FEBS Lett. 1990, 273, 99-102.
127. Okada, K.; Miyazaki, Y.; Takada, J.; Matsuyama, K.; Yamaki, T.; Yano, M. Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 1990,171, 1192-1198.
128. Ohnaka, K.; Takayanagi, R.; Yamauchi, T.; Okazaki, H.; Ohashi, M.; Umeda, F.; Nawata, H. Identification and characterization of endothelin converting activity in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 1990, 168, 1128-1136.
129. Matsumura, Y.; Ikegawa, R.; Tsukahara, Y.; Takaoka, M.; Morimoto, S. Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett. 1990, 272, 166-170.
130. Takada, J.; Okada, K.; Ikenaga, T.; Matsuyama, K.; Yano, M. Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 1991,176, 860-865.
131. Fukuroda, T.; Noguchi, K.; Tsuchida, S.; Nishikibe, M.; Ikemoto, F.; Okada, K.; Yano, M. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 1990,172, 390-395.
132. Matsumura, Y.; Hisaki, K.; Takaoka, M.; Morimoto, S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur. J. Pharmacol. 1990, 185, 103-106.
133. McMahon, E. G.; Palomo, M. A.; Moore, W. M.; McDonald, J. F.; Stern, M. K. Phosphoramidon blocks the pressor activity of porcine big endothelin-l-(1-39) in vivo and conversion of big endothelin-l-(1-39) to endothelin-l-(1-21) in vitro. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 703-707.
134. Vijayaraghavan, J.; Scicli, A. G.; Carretero, O. A.; Slaughter, C.; Moomaw, C.; Hersh, L. B. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem. 1990, 265, 14150-14155.
135. Biochot, E.; Pons, F.; Lagente, V.; Touvay, C.; Mencia-Huerta, J.; Braquet, P. Phosphoramidon potentiates the endothelin-l-induced bronchopulmonary response in guineapigs. Neurochem. Int. 1991,18, 477-479.
136. Modin, A.; Pernow, J.; Lundberg, J. M. Phosphoramidon inhibits the vasoconstrictor effects evoked by big endothelin-1 but not the elevation of plasma endothelin-1 in vivo. Life Sci. 1991, 49, 1619-1625.
137. Sessa, W. C.; Kaw, S.; Hecker, M.; Vane, J. R. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 1991,174, 613-618.
138. Arai, H.; Hori, S.; Aramori, I.; Ohkubo, H.; Nakanishi, S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (London) 1990, 348, 730-732.
139. Sakurai, T.; Yanagisawa, M.; Takuwa, Y.; Miyazaki, H.; Kimura, S.; Goto, K.; Masaki, T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London) 1990, 348, 732-735.
140. Lin, H. Y.; Kaji, E. H.; Winkel, G. K.; Ives, H. E.; Lodish, H. F. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 3185-3189.
141. Gomez, S. C.; Cozza, E. N.; Foecking, M. F.; Chiou, S.; Ferris, M. W. Endothelin receptor subtypes and stimulation of aldosterone secretion. Hypertension 1990, 15, 744-747.
142. Nambi, P.; Pullen, M.; Feuerstein, G. Identification of endothelin receptors in various regions of rat brain. Neuropeptides 1990,16, 195-199.
143. Emori, T.; Hirata, Y.; Marumo, F. Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action. FEBS Lett. 1990, 263, 261-264.
144. Williams, D. L.; Jones, K. L.; Pettibone, D. J.; Lis, E. V.; Clineschmidt, B. V. Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 1991,175, 556-561.
145. Takayanagi, R.; Kitazumi, K.; Takasaki, C.; Ohnaka, K.; Aimoto, S.; Tasaka, K.; Ohashi, M.; Nawata, H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 1991, 282, 103-106.
146. Saeki, T.; Ihara, M.; Fukuroda, T.; Yamagiwa, M.; Yano, M. [Ala1,3,11,15]Endothelin-1 analogs with ETB agonistic activity. Biochem. Biophys. Res. Commun. 1991, 179, 286-292.
147. Panek, R. L.; Major, T. C.; Hingorani, G. P.; Doherty, A. M.; Taylor, D. G.; Rapundalo, S. T. Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 1992, in press.
148. Perkins, T. D.; Hider, R. C.; Barlow, D. J. Proposed solution structure of endothelin. Int. J. Peptide Protein Res. 1990, 36, 128-133.
149. Saudek, V.; Hoflack, J.; Pelton, J. T. ‘H-NMR study of endothelin, sequence-specific assignment of the spectrum and a solution structure. FEBS Lett. 1989, 257, 145-148.
150. Endo, S.; Inooka, H.; Ishibashi, Y.; Kitada, C.; Mizuta, E.; Fujino, M. Solution conformation of endothelin determined by nuclear magnetic resonance and distance geometry. FEBS Lett. 1989, 257, 149-154.
151. Reily, M. D.; Dunbar, J. B. The conformation of endothelin-1 in aqueous solution. NMR-derived constraints combined with distance geometry and molecular mechanics calculations. Biochem. Biophys. Res. Commun. 1991,178, 570-577.
152. Kloog, Y.; Sokolovsky, M. Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol. Sci. 1989, 10, 212-214.
153. Nakajima, K.; Kumagaye, S.; Nishio, H.; Kuroda, H.; Watanabe, T. X.; Kobayashi, Y.; Tamaoki, H.; Kimura, T.; Sakakibara, S. Synthesis of endothelin-1 analogues, endothelin-3, and sarafotoxin S6b: structure-activity relationships. J. Cardiovasc. Pharmacol. 1989, 123 (Suppl. 5), S8-S12.
154. Takasaki, C.; Aimoto, S.; Kitazumi, K.; Tasaka, K.; Shiba, T.; Nishiki, K.; Furukawa, Y.; Takayanagi, R.; Ohnaka, K.; Nawata, H. Structure-Activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c. Eur. J. Pharmacol. 1991, 198, 165-169.
155. Takayanagi, R.; Hashiguchi, T.; Ohashi, M,; Nawata, H. Regional distribution of endothelin receptor in porcine cardiovascular tissues. Regul. Pept. 1990, 27, 247-255.
156. Hirata, Y.; Yoshimi, H.; Marumo, F.; Watanabe, T. X.; Kumagaye, S.; Nakajima, K.; Kimura, T.; Sakakibara, S. Interaction of synthetic sarafotoxin with rat vascular endothelin receptors. Biochem. Biophys. Res. Commun. 1989, 162, 441-447.
157. Takasaki, C.; Aimoto, S.; Takayanagi, R.; Ohashi, M.; Nawata, H. Structure-receptor binding relationships of sarafotoxin and endothelin in porcine cardiovascular tissues. Biochem. Int. 1990, 21, 1059-1064.
158. Kitazumi, K.; Shiba, T.; Nishiki, K.; Furukawa, Y.; Takasaki, C.; Tasaka, K. Structure-activity relationship in vasoconstrictor effects of sarafotoxins and endothelin-1. FEBS Lett. 1990, 260, 269-272.
159. Randall, M. D.; Douglas, S. A.; Hiley, C. R. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br. J. Pharmacol. 1989, 98, 685-699.
160. Kimura, S.; Kasuya, Y.; Sawamura, T.; Shinmi, O.; Sugita, Y.; Yanagisawa, M.; Goto, K.; Masaki, T. Structure-activity relationships of endothelin: importance of the C-terminal moiety. Biochem. Biophys. Res. Commun. 1988, 156, 1182-1186.
161. Nakajima, K.; Kubo, S.; Kumagaye, S.; Nishio, H.; Tsunemi, M.; Inui, T.; Kuroda, H.; Chino, N.; Watanabe, T. X.; Kimura, T.; et al. Structure-activity relationships of endothelin: importance of charged groups. Biochem. Biophys. Res. Commun. 1989, 163, 424-429.
162. Watanabe, T. X.; Itahara, Y.; Nakajima, K.; Kumagaye, S. I.; Kimura, T.; Sakakibara, S. Receptor binding affinity and biological activity of varied length of peptides elongated from C-terminal of endothelin. Jpn. J. Pharmacol. 1990, 52, P-040.
163. Maggi, C. A.; Giuliani, S.; Patacchini, R.; Rovero, P.; Giachetti, A.; Meli, A. The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur. J. Pharmacol. 1989,174, 23-31.
164. Rovero, P.; Patacchini, R.; Maggi, C. A. Structure-activity studies on endothelin (16-21), the C-terminal hexapeptide of the endothelins, in the guinea-pig bronchus. Br. J. Pharmacol. 1990,101, 232-234.
165. Doherty, A. M.; Cody, W. L.; Leitz, N. L.; DePue, P. L.; Taylor, M. D.; Rapundalo, S. T.; Hingorani, G. P.; Major, T. C. ; Panek, R. L.; Taylor, D. G. Structure-activity studies of the C-terminal region of the endothelins and sarafotoxins. J. Cardiovasc. Pharmacol. 1991,17 (Suppl. 7), S59-561.
166. Maggi, C. A.; Giuliani, S.; Patacchini, R.; Santicioli, P.; Rovero, P.; Giachetti, A.; Meli, A. The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur. J. Pharmacol. 1989, 166, 121-122.
167. Doherty, A. M.; Cody, W. L.; He, X.; DePue, P. L.; Leonard, D. M.; Dudley, D. T.; Rapundalo, S. T.; Hingorani, G. P.; Panek, R. L.; Major, T. C.; Hill, K. E.; Flynn, M. A.; Reynolds, E. E. Structure-activity relationships of endothelin receptor agonists and antagonists. 203rd National Meeting of the American Chemical Society, San Francisco, April 1992.
168. Johansen, N. L.; Lundt, B. F.; Madsen, K.; Olson, V. V.; Suzdak, P.; Thogerson, H.; Weiss, J. U. Structure-activity relationships of endothelin analogs. Peptides 1991, Proceedings 21st European Peptide Symposium, pp 680-681.
169. Hunt, J. T.; Lee, V. G.; Stein, P. D.; Hedberg, A.; Liu, E. C.; McMullen, D.; Moreland, S. Structure-activity relationships of monocyclic endothelin analogues. Bioorg. Med. Chem. Lett. 1991,1, 33-38.
170. Cohen, G.; Knight, M.; Lippton, H.; Hyman, A. Structural requirements for pulmonary vasodilation by endothelin. Circulation 1990, 82, III—227.
171. Spinella, M. J.; Malik, A. B.; Everitt, J.; Anderson, T. T. Design and synthesis of a specific endothelin 1 antagonist: Effects on pulmonary vasoconstriction. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 7443-7446.
172. Ihara, M.; Fukuroda, T.; Saeki, T.; Masaru, N.; Kojiri, K.; Suda, H.; Yano, M. An Endothelin Receptor Antagonist Isolated From Streptomyces Misakiensis. Biochem. Biophys. Res. Commun. 1991,178 (1), 132-137.
173. Fukami, T.; Hayama, T.; Niiyama, K.; Nagase, T.; Mase, T.; Fujita, K.; Kumagai, U.; Urakawa, Y.; Ihara, M.; Kimura, S.; Yano, M. Endothelin antagonistic cyclic pentapeptides with high selectivity for the ETA receptor. Twelfth American Peptide Symposium, Cambridge, MA, June 16-21,1991; 506.
174. Kiyofumi, I.; Takehiro, F.; Takashi, H.; Kenji, N.; Toshio, N.; Toshiaki, M.; Kagari, F.; Masaru, N.; Masaki, I.; Yano, M. EPA 0 436 189 Al; Endothelin antagonistic cyclic pentapeptides, Filed 20 December 1990.
175. Oohata, N.; Nishikawa, M.; Kiyoto, S.; Takase, S.; Hemmi, K.; Murai, H.; Okuhara, M. Anthraquinone derivatives and preparation thereof. European patent application 90112076.6, filed 26 June 1990.
176. Hashimoto, M.; Nishikawa, M.; Esaki, M.; Kiyoto, S.; Okuhara, M.; Takase, S.; Henmi, K.; Neya, M.; Fukami, N.; Hashimoto, M. JO 3130-299-A, filed August 8, 1990.
177. Keiji, H.; Masahiro, N.; Naoki, F.; Masashi, H.; Tanaka, H.; Kayakiri, N. Peptides having endothelin antagonist activity, a process for the preparation thereof and pharmaceutical compositions comprising the same. EPA 0457 195 A2, 9 May 1991.